Exclusion Criteria:~* Other cause of dementia.~* Previous use of symptomatic treatment for Alzheimer's
disease.~* Hypersensitivity to donepezil hydrochloride or to any of the excipients listed in the SPC.~*
Cardiological contraindication after possible opinion of a cardiologist, at the initiative of the investigator,
in particular bradycardia, sinus disease or other supra-ventricular conduction abnormalities such as sinoatrial
or atrioventricular block.~* Taking concomitant medications known to prolong the interval QTc~* Patients at
particular risk of ulcer, known ulcer disease or receiving concomitant treatment with non-steroidal
anti-inflammatory drugs.~* Patient at risk of urinary retention.~* History of epileptic disease.~* History of
neuroleptic malignant syndrome.~* History of asthma or obstructive bronchopulmonary disease.~* Severe hepatic
impairment.~* Taking one of the following treatments:~ * CYP3A4 inhibitors, such as ketonazole.~ * 2D6
inhibitors, such as quinidine.~ * CYP3A4 inhibitors, such as itraconazole and erythromycin.~ * CYP2D6
inhibitors, such as fluoxetine.~ * Enzyme inducers such as rifampicin, phenytoin, carbamazepine.~ *
Antiarrhythmic class IA agents~ * Antiarrhythmic class III agents~ * other Antipsychotics such as
phenothiazine, sertindole, pimozide, ziprasidone.~ * some antiobiotics such as clarithromycine, erythromycine,
levofloxacine, moxifloxacine.~* Participation in another interventional study.
